Literature DB >> 2245879

Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects.

T W Jones1, G McCarthy, W V Tamborlane, S Caprio, E Roessler, D Kraemer, K Starick-Zych, T Allison, S D Boulware, R S Sherwin.   

Abstract

To evaluate the impact of mild hypoglycemia on CNS function in healthy adults, we measured brain stem auditory evoked potentials and P300 potentials (elicited by cognitive processing of auditory stimuli) during hypoglycemic or euglycemic insulin clamps (80 mU.m-2.min-1). In the hypoglycemic clamp study (n = 8), plasma glucose was allowed to fall from 4.6 to 3 mM in hourly approximately 0.5-mM steps and subsequently returned to euglycemic baseline levels. In the euglycemic clamp study (n = 8), plasma glucose was maintained at baseline levels throughout. Neither brain stem nor P300 responses changed during the euglycemic control study; symptoms and counterregulatory hormones were also unaffected. During the hypoglycemia study, epinephrine and growth hormone rose once plasma glucose reached 3.4 +/- 0.1 mM. Brain stem and P300 potentials remained unchanged until the 3-mM glucose step, when neurophysiological changes suddenly developed in conjunction with reported symptoms. At this glucose level, the wave V component of the brain stem potential was selectively altered in 7 of 8 subjects. Furthermore, P300 latency significantly increased, and amplitude diminished. Changes in both brain stem and cortical (P300) responses reversed when euglycemia was restored. We conclude that modest reductions in plasma glucose (to 3 mM) produce marked alterations in both brain stem and cortical responses to auditory stimuli. These changes in neural function appear at the same time as symptoms and follow rather than precede the rise in counterregulatory hormones during hypoglycemia. Our data suggest that the adverse effects of mild hypoglycemia on brain function are not limited to higher centers but also involve the brain stem.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2245879     DOI: 10.2337/diab.39.12.1550

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Intrahippocampal administration of amyloid-β(1-42) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism.

Authors:  Jiah Pearson-Leary; Ewan C McNay
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury.

Authors:  David W Dowdy; Victoriano Dinglas; Pedro A Mendez-Tellez; O Joseph Bienvenu; Jonathan Sevransky; Cheryl R Dennison; Carl Shanholtz; Dale M Needham
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

3.  Effects of previous glycaemic control on the onset and magnitude of cognitive dysfunction during hypoglycaemia in type 1 (insulin-dependent) diabetic patients.

Authors:  D Ziegler; A Hübinger; H Mühlen; F A Gries
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

4.  Effects of relative hypoglycemia on LTP and NADH imaging in rat hippocampal slices.

Authors:  Matthew P Sadgrove; Christopher J Beaver; Dennis A Turner
Journal:  Brain Res       Date:  2007-07-24       Impact factor: 3.252

5.  Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.

Authors:  D Kerr; W V Tamborlane; F Rife; R S Sherwin
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

6.  Sudden Death Associated with Severe Hypoglycemia in a Diabetic Patient During Sensor-Augmented Pump Therapy with the Predictive Low Glucose Management System.

Authors:  Kota Nishihama; Kazuhito Eguchi; Kanako Maki; Yuko Okano; Soichiro Tanaka; Chisa Inoue; Akihiro Uchida; Mei Uemura; Toshinari Suzuki; Taro Yasuma; Corina N D'Alessandro-Gabazza; Esteban C Gabazza; Yutaka Yano
Journal:  Am J Case Rep       Date:  2021-01-19

Review 7.  Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.

Authors:  Clementine E M Verhulst; Therese W Fabricius; Steven Teerenstra; Peter L Kristensen; Cees J Tack; Rory J McCrimmon; Simon Heller; Mark L Evans; Stephanie A Amiel; Ulrik Pedersen-Bjergaard; Bastiaan E de Galan
Journal:  Diabetologia       Date:  2022-07-22       Impact factor: 10.460

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.